BR112017022941A2 - dispositivo de neuromodulação - Google Patents

dispositivo de neuromodulação

Info

Publication number
BR112017022941A2
BR112017022941A2 BR112017022941-2A BR112017022941A BR112017022941A2 BR 112017022941 A2 BR112017022941 A2 BR 112017022941A2 BR 112017022941 A BR112017022941 A BR 112017022941A BR 112017022941 A2 BR112017022941 A2 BR 112017022941A2
Authority
BR
Brazil
Prior art keywords
methods
treating
signal
neuromodulation device
provides
Prior art date
Application number
BR112017022941-2A
Other languages
English (en)
Inventor
John Chew Daniel
Jacob De Jonge Wouter
Jakob Kristoffer Famm Hans
Patel Sonal
Welting Olaf
Original Assignee
Galvani Bioelectronics Limited
Academisch Medisch Centrum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galvani Bioelectronics Limited, Academisch Medisch Centrum filed Critical Galvani Bioelectronics Limited
Publication of BR112017022941A2 publication Critical patent/BR112017022941A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551—Spinal or peripheral nerve electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551—Spinal or peripheral nerve electrodes
    • A61N1/0556—Cuff electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36135—Control systems using physiological parameters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)

Abstract

a invenção apresenta aparelhos, sistemas e métodos para o tratamento e melhora de inflamação do intestino. em particular, a invenção apresenta dispositivos, aparelhos e métodos em que um sinal neuromodulador é distribuído a um nervo esplênico e/ou plexo mesentérico superior (smp). o sinal é capaz de tratar distúrbios inflamatórios, por exemplo, colite, por exemplo, em doença inflamatória intestinal.
BR112017022941-2A 2015-04-24 2016-04-22 dispositivo de neuromodulação BR112017022941A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562152119P 2015-04-24 2015-04-24
US62/152,119 2015-04-24
PCT/IB2016/052307 WO2016170510A1 (en) 2015-04-24 2016-04-22 Neuromodulation device

Publications (1)

Publication Number Publication Date
BR112017022941A2 true BR112017022941A2 (pt) 2018-07-17

Family

ID=55963419

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017022941-2A BR112017022941A2 (pt) 2015-04-24 2016-04-22 dispositivo de neuromodulação

Country Status (11)

Country Link
US (2) US10974041B2 (pt)
EP (2) EP3950049A1 (pt)
JP (1) JP2018514354A (pt)
KR (1) KR20180040516A (pt)
CN (1) CN108290041A (pt)
AU (1) AU2016252497A1 (pt)
BR (1) BR112017022941A2 (pt)
CA (1) CA2983652A1 (pt)
MA (1) MA41950A (pt)
RU (1) RU2017140776A (pt)
WO (1) WO2016170510A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180193643A1 (en) * 2015-06-05 2018-07-12 The Johns Hopkins University Method and device for sacral nerve stimulation
PL3481285T3 (pl) 2016-07-07 2021-03-08 The Regents Of The University Of California Implanty wykorzystujące fale ultradźwiękowe do stymulacji tkanek
WO2019122906A1 (en) 2017-12-20 2019-06-27 Galvani Bioelectronics Limited Treatment of acute medical conditions
US11633601B2 (en) 2017-12-20 2023-04-25 Galvani Bioelectronics Limited Treatment of inflammatory disorders
CN111954554A (zh) 2017-12-20 2020-11-17 加尔瓦尼生物电子有限公司 急性医学病况的治疗
JP2021507759A (ja) * 2017-12-20 2021-02-25 ガルバニ バイオエレクトロニクス リミテッド 炎症に関連する疾患の治療
WO2019122903A2 (en) * 2017-12-20 2019-06-27 Galvani Bioelectronics Limited Stimulation of a nerve supplying the spleen
CN112351812A (zh) * 2018-04-19 2021-02-09 艾奧塔生物科技公司 用于调节脾神经活动的使用超声通信的植入物
BR112020021383A2 (pt) 2018-04-19 2021-01-26 Iota Biosciences, Inc. implantes que usam comunicação ultrassônica para detecção e estimulação neural
KR20210053915A (ko) 2018-08-29 2021-05-12 아이오타 바이오사이언시즈 인코퍼레이티드 이식 가능한 폐회로 뉴로모듈레이션 장치, 시스템 및 사용 방법
US20220347470A1 (en) * 2018-12-20 2022-11-03 Galvani Bioelectronics Limited Neurostimulation device for blocking blood flow between electrodes
EP3986532A1 (en) * 2019-06-19 2022-04-27 Galvani Bioelectronics Limited System for the treatment of disorders associated with inflammation
WO2020254798A1 (en) * 2019-06-19 2020-12-24 Galvani Bioelectronics Limited Stimulation of a nerve supplying the spleen
EP3986531A1 (en) * 2019-06-19 2022-04-27 Galvani Bioelectronics Limited Treatment of acute medical conditions
WO2022122833A1 (en) * 2020-12-09 2022-06-16 Galvani Bioelectronics Limited Physiological effects of activation of the alox15 pathway
CN113197587A (zh) * 2021-04-26 2021-08-03 中国科学院深圳先进技术研究院 一种用于迷走神经刺激和电生理检测的装置及植入方法
WO2023017253A1 (en) * 2021-08-10 2023-02-16 Galvani Bioelectronics Limited Neuromodulation device
KR20230078121A (ko) * 2021-11-26 2023-06-02 주식회사 뉴라이브 동물용 미주신경 자극장치
CN114177472A (zh) * 2021-11-30 2022-03-15 中国人民解放军总医院第四医学中心 一种应用于下肢假肢的植入式电刺激感知反馈系统

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7389145B2 (en) 2001-02-20 2008-06-17 Case Western Reserve University Systems and methods for reversibly blocking nerve activity
US20060116736A1 (en) * 2001-07-23 2006-06-01 Dilorenzo Daniel J Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of obesity
US7418292B2 (en) * 2003-10-01 2008-08-26 Medtronic, Inc. Device and method for attenuating an immune response
US20050075702A1 (en) * 2003-10-01 2005-04-07 Medtronic, Inc. Device and method for inhibiting release of pro-inflammatory mediator
US8214047B2 (en) * 2004-09-27 2012-07-03 Advanced Neuromodulation Systems, Inc. Method of using spinal cord stimulation to treat gastrointestinal and/or eating disorders or conditions
WO2006073484A2 (en) 2004-12-27 2006-07-13 North Shore-Long Island Jewish Research Institute Treating inflammatory disorders by electrical vagus nerve stimulation
EP1948301B8 (en) * 2005-11-10 2014-03-12 ElectroCore LLC Electrical stimulation treatment of bronchial constriction
JP2009525805A (ja) * 2006-02-10 2009-07-16 エレクトロコア、インコーポレイテッド 電気的変調を用いたアナフィラキシーの治療方法および治療装置
US9539425B2 (en) * 2006-10-13 2017-01-10 Intelect Medical, Inc. Systems and methods for treating medical conditions by stimulation of medial thalamic region
WO2008096730A1 (ja) * 2007-02-09 2008-08-14 National University Corporation Nagoya University 抗炎症剤及びその用途
US20090275997A1 (en) * 2008-05-01 2009-11-05 Michael Allen Faltys Vagus nerve stimulation electrodes and methods of use
US8788034B2 (en) * 2011-05-09 2014-07-22 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
EP3132827B1 (en) * 2010-12-28 2019-04-03 Cibiem, Inc. Endovascular carotid body ablation catheter for sympathetic rebalancing of patient
WO2012159002A2 (en) 2011-05-19 2012-11-22 Neuros Medical, Inc. High-frequency electrical nerve block
AU2012347470B2 (en) 2011-12-09 2017-02-02 Medtronic Ireland Manufacturing Unlimited Company Therapeutic neuromodulation of the hepatic system
WO2013124541A1 (en) * 2012-02-24 2013-08-29 Nokia Corporation Method and apparatus for dynamic server|client controlled connectivity logic
US11013549B2 (en) * 2012-03-08 2021-05-25 Medtronic Ardian Luxembourg S.A.R.L. Gastrointestinal neuromodulation and associated systems and methods
WO2014153223A1 (en) * 2013-03-14 2014-09-25 Perryman Laura Tyler Treating inflammation, chronic pain and other disorders with neuromodulation

Also Published As

Publication number Publication date
CA2983652A1 (en) 2016-10-27
EP3285856A1 (en) 2018-02-28
EP3950049A1 (en) 2022-02-09
US20210393949A1 (en) 2021-12-23
CN108290041A (zh) 2018-07-17
MA41950A (fr) 2018-02-28
KR20180040516A (ko) 2018-04-20
WO2016170510A1 (en) 2016-10-27
RU2017140776A (ru) 2019-05-24
US10974041B2 (en) 2021-04-13
US20180117319A1 (en) 2018-05-03
AU2016252497A1 (en) 2017-11-09
JP2018514354A (ja) 2018-06-07

Similar Documents

Publication Publication Date Title
BR112017022941A2 (pt) dispositivo de neuromodulação
IL281566A (en) Methods and systems for diagnosing and treating diseases
HK1252823A1 (zh) 用於治療性鼻神經調節的裝置及相關的方法和系統
EP3740274A4 (en) SYSTEMS AND METHODS FOR TREATING INFLAMMATORY INTESTINAL DISEASE USING PERIPHERAL NERVE STIMULATION
BR112017007767A2 (pt) canabidiol para uso, método para tratar um paciente que sofre de complexo esclerose tuberosa, e, composição.
BR112017013022A2 (pt) métodos para tratar uma doença inflamatória e/ou autoimune aguda num mamífero que a necessite onde a terapia de corticosteróides é utilizada como terapia de primeira ou segunda linha e/ou para tratar uma doença inflamatória e/ou autoimune num mamífero que a necessite, onde a terapia de corticosteróides é utilizada como terapia de manutenção de primeira ou segunda linha e/ou para eliminar ou reduzir dose terapêutica de corticosteróides utilizado no tratamento de uma doença inflamatória e/ou autoimune num mamífero que a necessite, onde a terapia de corticosteróides é utilizada como terapia de manutenção crônica de primeira ou segunda linha e/ou de tratamento de uma doença autoimune e/ou inflamatória num mamífero que a necessite
BR112017006664A2 (pt) terapias de combinação
EP3288635A4 (en) SYSTEMS AND METHODS FOR TARGETED UVB LIGHT THERAPY AGAINST AUTOIMMUNE DISEASES AND OTHER INDICATIONS
BR112017003163A2 (pt) dispositivo de infraestrutura modular, sistema de infraestrutura e processo para operação de um dispositivo de infraestrutura
FR3032353B1 (fr) Composition pharmaceutique et dispositif pour le traitement de la douleur
BR112018012130A2 (pt) dispostivo de processamento de dados, e método para a verificação da integridade de um dispositivo de processamento de dados tendo uma pluralidade de componentes de hardware
CL2016001076A1 (es) (aza) piridopirazolopirimidinonas e indazolopirimidinonas como inhibidores de fibrinolosis.
HUE054828T2 (hu) Eljárások és készítmények a bél enteroendokrin rendszerének stimulálására a vele kapcsolatos betegségek és állapotok kezelésére
TN2017000074A1 (en) Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof
BR112018000707A2 (pt) ?composições terapêuticas e produto de combinação?
JOP20190025A1 (ar) طرق وتركيبة لتوقع نشاط إنزاستورين
GB2561300B (en) Method and system for diagnosing disease and generating treatment recommendations
BR112017026803A2 (pt) adaptador ou sistema adaptador para tornar dispositivos médicos funcionalmente estéreis
BR112017018068A2 (pt) dispositivo de neuromodulação
MX370436B (es) Composicion farmaceutica para usarse en el tratamiento o la prevencion de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a cirugia de derivacion gastrica.
FR3027826B1 (fr) Systeme et procede de traitement local de surface
IL242323B (en) Device, system, and method for the treatment of liquid waste waters
FR3045568B1 (fr) Dispositif de degivrage, installation de degivrage et procede de configuration d'une installation de degivrage
FR3042420B1 (fr) Dispositif de traitement par phototherapie
FR3019920B1 (fr) Equipement de substitution d'un equipement avionique d'affichage; systeme et module associes

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]